Autophagy regulation of apoptosis and necroptosis within cell populations
Autophagy regulation of apoptosis and necroptosis within cell populations
批准号:
10238836
负责人:
James V Degregori
金额:
$35.39万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
未结题
起止时间:
2010-04-19 至 2025-04-30
关键词:
Antineoplastic AgentsApoptosisApoptoticAutophagocytosisBBC3 geneBCL2L11 geneBH3 DomainBinding SitesCell DeathCellsCessation of lifeClinicalClinical TrialsComplexCytotoxic agentDoseDrug resistanceEvolutionExposure toFOXO3A geneFundingFutureGenesGeneticGoldGrantHeterogeneityHuman GenomeIntronsMalignant NeoplasmsMethodsMolecularMutationNecrosisOuter Mitochondrial MembranePathway interactionsPharmaceutical PreparationsPharmacologyPhosphotransferasesPopulationProcessProteinsRIPK3 geneRecyclingRegulationReportingResistanceSignal TransductionStimulusTP53 geneTechniquesTertiary Protein StructureTestingVariantWorkbasecancer cellcancer therapycell typeimprovedinhibitor/antagonistinsightintervention effectneoplastic cellnovelnovel strategiesoptogeneticsoutcome predictionresponsescaffoldside effecttherapy resistanttranscription factortreatment responsetumor heterogeneity
中文摘要
细胞死亡中一个重要的未解决的问题是理解为什么群体中的不同细胞在
他们的反应。哪些细胞会存活或死亡,以及在暴露于
死亡刺激?这些问题是基本细胞命运决定的基础,也具有重要的实际意义。
例如,在癌症治疗过程中,当对抗癌药物的非遗传性、异质性反应
药物是最终对治疗产生耐药性的基础。细胞反应中的异源性可以被驱动
通过细胞间稳定的遗传差异,这很容易理解。然而,这种差异也
甚至发生在遗传同质的细胞群体中。这些差异背后的原因是什么?更重要的是,
我们能控制这些效应吗这项资助支持的先前工作发现,即使在一个
在非应激条件下的细胞同质群体中,
自噬通量,这反过来又预测了未来用死亡刺激治疗的结果。后者在
基金期间,我们发现了一种特定的机制,自噬控制凋亡阈值,
这是自噬机制控制坏死性凋亡的一种完全不同的机制。根据这些
在以前的研究中,我们假设:自噬通过调节细胞凋亡和坏死性凋亡阈值,
线粒体外膜透化(MOMP)。这就解释了细胞之间的死亡差异
在人口中。我们将通过使用各种新的方法完成以下目标来测试这一假设。
包括第一种允许光遗传学调节自噬的方法。具体目标1。测试是否
死亡刺激前后的自噬变化控制细胞凋亡反应的异质性
人口具体目标2。确定自噬如何调节坏死性凋亡。通过实现这些目标,我们
将获得新的见解之间的相互作用的两种主要形式的程序性细胞死亡(凋亡和
necroptosis)并揭示自噬如何调节这些过程。
英文摘要
An important unsolved question in cell death is to understand why different cells within a population vary in
their responses. Which cells will live or die and what determines exactly how they die after exposure to a
death stimulus? These questions underlie fundamental cell fate decisions and also have important practical
ramifications, for example, during cancer therapy when non-heritable, heterogeneous responses to anti-cancer
drugs underlie the eventual acquisition of resistance to therapy. Heterogeneity in cell responses can be driven
by stable genetic differences between cells, which are easy to understand. However, such differences also
occur even in genetically homogeneous cell populations. What underlies these differences? More important,
can we manipulate these effects? Previous work supported by this grant discovered that even in a
homogeneous population of cells under unstressed conditions, there is extensive variation in the amount of
autophagic flux, which in turn predicts the outcome to future treatment with a death stimulus. And, in the last
funding period, we discovered a specific mechanism by which autophagy controls the apoptosis threshold and
a quite different mechanism by which the autophagy machinery can control necroptosis. Building on these
previous studies, we hypothesize: autophagy controls apoptotic and necroptotic thresholds by regulating
Mitochondrial Outer Membrane Permeabilization (MOMP). And, this explains cell death variation between cells
in a population. We will test this hypothesis by completing the following aims using a variety of new
approaches including the first method that allows optogenetic regulation of autophagy. Specific Aim 1. Test if
autophagy variation before and after a death stimulus controls heterogeneity in apoptosis responses in a cell
population. Specific Aim 2. Determine how autophagy regulates necroptosis. By completing these aims, we
will gain new insights into the interplay between two major forms of programmed cell death (apoptosis and
necroptosis) and uncover how autophagy regulates these processes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of aging and clonal hematopoiesis on epigenetic heterogeneity, evolvability, and leukemogenesis
-
批准号:10700071
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2021
-
负责人:James V Degregori
-
依托单位:
Impact of aging and clonal hematopoiesis on epigenetic heterogeneity, evolvability, and leukemogenesis
-
批准号:10353178
-
项目类别:
-
资助金额:$42.31万
-
财政年份:2021
-
负责人:James V Degregori
-
依托单位:
Impact of aging and clonal hematopoiesis on epigenetic heterogeneity, evolvability, and leukemogenesis
-
批准号:10493345
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2021
-
负责人:James V Degregori
-
依托单位:
The impact of reduction of cellular senescence on age-related epigenetic heterogeneity
-
批准号:10830053
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2021
-
负责人:James V Degregori
-
依托单位:
Aged tissue environments as drivers of oncogenic adaptation in hematopoiesis
-
批准号:10319990
-
项目类别:
-
资助金额:$25.02万
-
财政年份:2020
-
负责人:James V Degregori
-
依托单位:
Aged tissue environments as drivers of oncogenic adaptation in hematopoiesis
-
批准号:10541835
-
项目类别:
-
资助金额:$24.59万
-
财政年份:2020
-
负责人:James V Degregori
-
依托单位:
Dissecting the Role of Inflammation in Smoking and Aging Associated Lung Cancers
-
批准号:10454873
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:James V Degregori
-
依托单位:
Dissecting the Role of Inflammation in Smoking and Aging Associated Lung Cancers
-
批准号:10683147
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:James V Degregori
-
依托单位:
Amy Briggs Diversity Supplement R01AG067584
-
批准号:10273522
-
项目类别:
-
资助金额:$3.06万
-
财政年份:2019
-
负责人:James V Degregori
-
依托单位:
Determining how aging-associated changes in the microenvironment contribute to leukemogenesis
-
批准号:10176352
-
项目类别:
-
资助金额:$43.92万
-
财政年份:2019
-
负责人:James V Degregori
-
依托单位:
Determining how aging-associated changes in the microenvironment contribute to leukemogenesis
-
批准号:10406996
-
项目类别:
-
资助金额:$37.72万
-
财政年份:2019
-
负责人:James V Degregori
-
依托单位:
Determining how aging-associated changes in the microenvironment contribute to leukemogenesis
-
批准号:10020895
-
项目类别:
-
资助金额:$37.83万
-
财政年份:2019
-
负责人:James V Degregori
-
依托单位:
Determining how aging-associated changes in the microenvironment contribute to leukemogenesis
-
批准号:10668637
-
项目类别:
-
资助金额:$6.19万
-
财政年份:2019
-
负责人:James V Degregori
-
依托单位:
Dissecting the Role of Inflammation in Smoking and Aging Associated Lung Cancers
-
批准号:9894635
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:James V Degregori
-
依托单位:
Dissecting the Role of Inflammation in Smoking and Aging Associated Lung Cancers
-
批准号:10265400
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:James V Degregori
-
依托单位:
Nrf2-mediated impaired hematopoietic stem cell fitness following irradiation
-
批准号:8813763
-
项目类别:
-
资助金额:$16.88万
-
财政年份:2014
-
负责人:James V Degregori
-
依托单位:
Aging-associated alterations in adaptive landscapes and the evolution of leukemia
-
批准号:8725101
-
项目类别:
-
资助金额:$30.95万
-
财政年份:2013
-
负责人:James V Degregori
-
依托单位:
Aging-associated alterations in adaptive landscapes and the evolution of leukemia
-
批准号:9086311
-
项目类别:
-
资助金额:$34.5万
-
财政年份:2013
-
负责人:James V Degregori
-
依托单位:
Aging-associated alterations in adaptive landscapes and the evolution of leukemia
-
批准号:8588008
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2013
-
负责人:James V Degregori
-
依托单位:
Aging-associated alterations in adaptive landscapes and the evolution of leukemia
-
批准号:9278007
-
项目类别:
-
资助金额:$34.49万
-
财政年份:2013
-
负责人:James V Degregori
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: